Risk of myelodysplastic syndrome and myeloproliferative neoplasms in patients with stable coronary artery disease and autoimmune conditions treated with colchicine.

Authors: Ahmad Safdar, Omer Ashruf, Ali Mushtaq, Cole Thompson, Zara Orozco, Akriti G. Jain, Sophia Balderman, John C. Molina, Anjali S. Advani, Hetty E. Carraway, Aaron Thomas Gerds, Moaath Khader Mustafa Ali, Sudipto Mukherjee, Wen Ma, Alex A. Adjei, David Kaelber, Abhay Singh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18581

Source: Full article

---

Abstract

e18581